EDIT : Editas Medicine stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 11 Wall Street analysts offering Editas Medicine stock forecast in the last 6 months have average price target of $49.82 with a high forecast of $77.0 and a low forecast of $14.0. The average Editas Medicine stock forecast represents a 26.25% increase from the last price of $39.46. From AI system, total return is 2022.2% from 1610 forecasts. For Editas Medicine stock forecast 2021, 8 predictions are offered for each month of 2021 with average Editas Medicine stock forecast of $40.19, a high forecast of $41.43, and a low forecast of $39.71. The average Editas Medicine stock forecast 2021 represents a 1.85% increase from the last price of $39.46. For Editas Medicine stock forecast 2022, 12 predictions are offered for each month of 2022 with average Editas Medicine stock forecast of $36.37, a high forecast of $40.82, and a low forecast of $33.33. The average Editas Medicine stock forecast 2022 represents a -7.83% decrease from the last price of $39.46. For Editas Medicine stock forecast 2025, 12 predictions are offered for each month of 2025 with average Editas Medicine stock forecast of $35.05, a high forecast of $38.94, and a low forecast of $30.55. The average Editas Medicine stock forecast 2025 represents a -11.17% decrease from the last price of $39.46. For Editas Medicine stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Editas Medicine stock forecast of $33.55, a high forecast of $38.7, and a low forecast of $29.55. The average Editas Medicine stock forecast 2026 represents a -14.97% decrease from the last price of $39.46. For Editas Medicine stock forecast 2030, 12 predictions are offered for each month of 2030 with average Editas Medicine stock forecast of $35.4, a high forecast of $39.24, and a low forecast of $30.92. The average Editas Medicine stock forecast 2030 represents a -10.28% decrease from the last price of $39.46. For Editas Medicine stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $31.56, a high forecast of $33.27, and a low forecast of $30.63. The average Editas Medicine stock forecast 2031 represents a -20.02% decrease from the last price of $39.46. Please, see more forecasts below.